EMQAX
Price
$7.93
Change
-$0.04 (-0.50%)
Updated
Sep 20 closing price
FNWFX
Price
$83.10
Change
-$0.10 (-0.12%)
Updated
Sep 20 closing price
Ad is loading...

EMQAX vs FNWFX

Header iconEMQAX vs FNWFX Comparison
Open Charts EMQAX vs FNWFXBanner chart's image
Ashmore Emerging Markets Active Eq A
Price$7.93
Change-$0.04 (-0.50%)
VolumeN/A
CapitalizationN/A
American Funds New World F3
Price$83.10
Change-$0.10 (-0.12%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
EMQAX vs FNWFX Comparison Chart
Loading...
VS
EMQAX vs. FNWFX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMQAX is a Buy and FNWFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 63.1B vs. EMQAX (22.1M). FNWFX pays higher dividends than EMQAX: FNWFX (1.56) vs EMQAX (1.40). EMQAX was incepted earlier than FNWFX: EMQAX (8 years) vs FNWFX (8 years). EMQAX is a more actively managed with annual turnover of: 189.00 vs. FNWFX (32.00). EMQAX has a lower initial minimum investment than FNWFX: EMQAX (1000) vs FNWFX (1000000). FNWFX annual gain was more profitable for investors over the last year : 18.70 vs. EMQAX (17.01). FNWFX return over 5 years is better than : 25.74 vs. EMQAX (-18.31).
EMQAXFNWFXEMQAX / FNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years8 years-
Gain YTD12.20410.800113%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets22.1M63.1B0%
Annual Yield % from dividends1.401.5690%
Returns for 1 year17.0118.7091%
Returns for 3 years-32.72-9.66339%
Returns for 5 years-18.3125.74-71%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NTNX60.821.83
+3.10%
Nutanix
DMAC4.130.09
+2.23%
DiaMedica Therapeutics
BNL18.73-0.03
-0.16%
Broadstone Net Lease
CATX13.23-0.24
-1.78%
Perspective Therapeutics
CLWT1.63-0.06
-3.55%
Euro Tech Holdings Company Limited